Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Cipla Limited (BSE: 5
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Drug firm Alembic Pharmaceuticals on Monday said it has received establishment inspection report (EIR) from the US health regulator for its new injectable facility at Karakhadi in Gujarat.
The company has, ”received EIR from US Food and Drug Administration (USFDA) for the inspection carried out by them at our new injectable facility at Karakhadi during the period from January 28, 2021 to February 6, 2021, indicating that the USFDA finds our responses to their observations to be adequate,” Alembic Pharmaceuticals said in a regulatory filing.
The US regulator has also indicated that a compliance verification would be performed during re-inspection of the said facility in the next review cycle, it added.
Shares of Alembic Pharmaceuticals closed at Rs 819.45 per scrip on BSE, up 5.42 per cent from its previous close.
